Amgen seeks quick appeal in CareFirst's US case over Enbrel
MLex Summary: Amgen asked a US federal judge to certify for immediate appeal CareFirst's case accusing it of unlawfully delaying competition for its drug Enbrel after Amgen’s motion to dismiss was...To view the full article, register now.
Already a subscriber? Click here to view full article